<!DOCTYPE doctype html>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <link href="./style.css" rel="stylesheet" type="text/css"/>
  
  <title id="pageTitle">
   # 036 Calculating Opioid Dose Conversions, 2nd ed
  </title>

 </head>
 <body>

   <div id="mainBody">
    <!--/pageTopArea -->
    <div id="contentArea">
     <div id="contentContainer">
      <!--/toolContainer -->
      <div id="centerZone">
       <div id="titleBarContainer">
        <h3>
         # 036 Calculating Opioid Dose Conversions, 2nd ed
        </h3>
       </div>
       <!--/titleBarContainer -->
       <div blockinfo="Freeform CenterZone BlockID1" class="Freeform CenterZone BlockID1">
        
        <p>
         <br/>
         <b>
          Author(s):
         </b>
         Robert Arnold MD and David E Weissman MD
        </p>
        <p>
         <b>
          Introduction
         </b>
         A variety of published conversion tables exist to provide clinicians a rough guide for making calculations when switching between different opioid routes or preparations. Listed below are methods for common conversions using standard published conversion ratios. The examples assume a change in drug or route at a time of stable pain control using equianalgesic doses. See
         <a href="./ff_002.htm" linktype="4" target="_blank">
          <i>
           Fast Fact
          </i>
          #2
         </a>
         about conversions involving transdermal fentanyl;
         <a href="./ff_075.htm" linktype="4" target="_blank">
          Fast Fact #75
         </a>
         and
         <a href="./ff_086.htm" linktype="4" target="_blank">
          #86
         </a>
         about methadone; and
         <a href="./ff_181.htm" linktype="4" target="_blank">
          #181
         </a>
         about oxymorphone.
        </p>
        <p>
         <b>
          Caution:
         </b>
         Published values in equianalgesic tables should be considered a rough clinical guide when making dose conversions; substantial inter-individual variation exists. The final prescribed dose needs to take into account a patients’ age, renal, pulmonary and hepatic function; their current pain level and opioid side effects such as sedation; as well as prior and current opioid use.
        </p>
        <p>
         <u>
          <b>
           Opioid Equianalgesic Conversion Ratios for use with the following examples:
          </b>
         </u>
         <br/>
         Morphine 10 mg parenteral = Morphine 30 mg oral = Hydromorphone 1.5 mg parenteral = Hydromorphone 7.5 mg oral (see Reference 1).
        </p>
        <ol type="A">
         <li>
          <b>
           Change route, keeping drug the same (e.g. oral to IV morphine)
          </b>
          <ul>
           <li>
            Example: Change 90 mg q12 Extended Release Morphine to Morphine by IV continuous infusion
            <ol type="1">
             <li>
              Calculate the 24 hour current dose: 90mg q 12 = 180 mg Morphine/24 hours
             </li>
             <li>
              Use the oral to parenteral equianalgesic ratio: 30 mg PO Morphine = 10 mg IV Morphine
             </li>
             <li>
              Calculate new dose using ratios: 180/30 x 10 = 60 mg IV Morphine/24 hours or 2.5 mg/hour infusion
             </li>
             <li>
              Some experts recommend starting the new opioid at 75% of the calculated dose to account for inter-individual variation in first pass clearance.
             </li>
            </ol>
           </li>
          </ul>
         </li>
         <li>
          <b>
           Change drug, keep the same route (e.g. po morphine to po hydromorphone)
          </b>
          <ul>
           <li>
            There is incomplete cross-tolerance between different opioids, but the exact amount will differ. Thus, equianalgesic tables are only approximations. Depending on age and prior side effects, most experts recommend starting a new opioid at 50% of the calculated equianalgesic dose, in the setting of well-controlled pain.
            <ol type="1">
             <li>
              Example: Change 90 mg q 12 Extended Release Morphine to oral Hydromorphone.
             </li>
             <li>
              Calculate the 24 hour current dose: 90 Q12 x 2 = 180 mg PO Morphine/24 hrs
             </li>
             <li>
              Use the equianalgesic ratio: 30 mg PO Morphine = 7.5 mg PO Hydromorphone
             </li>
             <li>
              Calculate new dose using ratios: 180/30 X 7.5 = 45 mg oral Hydromorphone/24 hours.
             </li>
             <li>
              Reduce dose 50% for cross-tolerance: 45 x 0.5 = 22 mg/24 hours = 4 mg q4h
             </li>
            </ol>
           </li>
          </ul>
         </li>
         <li>
          <b>
           Changing drug and route (e.g. oral morphine to IV hydromorphone)
          </b>
          <ul>
           <li>
            Example: Change from 90 mg q12 Extended Release Morphine to IV Hydromorphone as a continuous infusion.
            <ol type="1">
             <li>
              Calculate the 24 hour current dose: 90 Q12 x 2 = 180 mg PO Morphine/24 hrs
             </li>
             <li>
              Use the equianalgesic ratio of PO to IV morphine: 30 mg po Morphine = 10 mg IV Morphine
             </li>
             <li>
              Calculate new dose using ratios: 180/30 x 10 = 60 mg IV Morphine/24 hours
             </li>
             <li>
              Use the equianalgesic ratio of IV Morphine to IV Hydromorphone: 10 mg Morphine = 1.5 mg Hydromorphone
             </li>
             <li>
              Calculate new dose using ratios: 60/10 x 1.5 = 9 mg IV Hydromorphone/24 hours
             </li>
             <li>
              Reduce dose 50% for cross-tolerance: 9 x 0.5 = 4.5 mg/24 hours = 0.2 mg IV continuous infusion
             </li>
            </ol>
           </li>
          </ul>
         </li>
        </ol>
        <p>
         <b>
          References
         </b>
        </p>
        <ol>
         <li>
          Gammaitoni AR, Fine P, Alvarez N, McPherson ML. Clinical application of opioid equianalgesic data. Clin J Pain. 2003; 19:286-297.
         </li>
         <li>
          Pereira J et al. Equianalgesic dose rations for opioids: a critical review and proposals for long-term dosing. J Pain Sym Manage. 2001; 22:672-687.
         </li>
         <li>
          Anderson R et al. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Sym Manage. 2001; 21:397-406.
         </li>
        </ol>

        <p>
         <b>
          Version History:
         </b>
         This Fast Fact was originally edited by David E Weissman MD. 2nd Edition published July 2005. Current version re-copy-edited March 2009; references updated.
        </p>
        
        <p>
         <b>
          ACGME Competencies:
         </b>
         Medical Knowledge
        </p>
        <p>
         <b>
          Keyword(s):
         </b>
         Pain – Opioids
        </p>
       </div>
      </div>
      <!--/centerZone -->
      <div id="rightZone">
      </div>
      <!--/rightZone -->
     </div>
     <!--/contentContainer -->
    </div>
    <!-- /contentArea -->
    <!--/bottomContainer -->
   </div>
   <!--/mainBody -->
   

 </body>
</html>
